Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2003 | 06-2003 | 12-2002 | 06-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 280 | 320 | 790 | 790 | 10 |
| Marketable Securities | 1,300 | 2,090 | 2,870 | 2,870 | 0 |
| Receivables | 0 | 0 | 70 | 70 | 0 |
| Other current assets | 60 | 190 | 70 | 70 | 20 |
| TOTAL | $1,640 | $2,600 | $3,800 | $3,800 | $30 |
| Non-Current Assets | |||||
| PPE Net | 60 | 70 | 70 | 70 | 70 |
| Investments And Advances | 7 | 0 | 990 | 990 | 0 |
| Other Non-Current Assets | 740 | 577 | 347 | 347 | 157 |
| TOTAL | $807 | $647 | $1,407 | $1,407 | $227 |
| Total Assets | $2,460 | $3,260 | $5,230 | $5,230 | $270 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20 | 50 | 80 | 80 | 160 |
| Accrued Expenses | 400 | 260 | 290 | 290 | 260 |
| TOTAL | $430 | $310 | $370 | $370 | $430 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 90 | 90 | 60 | 60 | 40 |
| TOTAL | $90 | $90 | $60 | $60 | $40 |
| Total Liabilities | $520 | $400 | $440 | $440 | $480 |
| Shareholders' Equity | |||||
| Common Shares | 120 | 110 | 110 | 110 | 70 |
| Retained earnings | -11,690 | -9,490 | -7,430 | -7,430 | -5,490 |
| Other shareholders' equity | 0 | 0 | -50 | -50 | -240 |
| TOTAL | $1,940 | $2,850 | $4,780 | $4,780 | $-200 |
| Total Liabilities And Equity | $2,460 | $3,250 | $5,220 | $5,220 | $280 |